These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 37158468

  • 1. Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety.
    Saloner B, Whitley P, Dawson E, Passik S, Gordon AJ, Stein BD.
    Addiction; 2023 Aug; 118(8):1549-1556. PubMed ID: 37158468
    [Abstract] [Full Text] [Related]

  • 2. Analysis of Urine Drug Test Results From Substance Use Disorder Treatment Practices and Overdose Mortality Rates, 2013-2020.
    Whitley P, LaRue L, Fernandez SA, Passik SD, Dawson E, Jackson RD.
    JAMA Netw Open; 2022 Jun 01; 5(6):e2215425. PubMed ID: 35657623
    [Abstract] [Full Text] [Related]

  • 3. Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs.
    Hughto JMW, Tapper A, Rapisarda SS, Stopka TJ, Palacios WR, Case P, Silcox J, Moyo P, Green TC.
    Subst Abuse Treat Prev Policy; 2023 May 22; 18(1):30. PubMed ID: 37217975
    [Abstract] [Full Text] [Related]

  • 4. Definitive urine drug test findings in patients prescribed opioids for pain from a large national database.
    Guevara MG, LaRue L, Zacharoff KL, Whitley P, Dawson E, Passik SD.
    J Opioid Manag; 2022 May 22; 18(4):361-375. PubMed ID: 36052933
    [Abstract] [Full Text] [Related]

  • 5. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
    LaRue L, Twillman RK, Dawson E, Whitley P, Frasco MA, Huskey A, Guevara MG.
    JAMA Netw Open; 2019 Apr 05; 2(4):e192851. PubMed ID: 31026029
    [Abstract] [Full Text] [Related]

  • 6. Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database.
    Saloner B, Whitley P, LaRue L, Dawson E, Huskey A.
    JAMA Netw Open; 2021 Sep 01; 4(9):e2123019. PubMed ID: 34505888
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The Cyclical and Evolving Nature of Methamphetamine Use: An Evaluation of Near Real-time Urine Drug Test Results.
    LaRue L, Guevara MG, Whitley P, Dawson E, Twillman RK, Huskey A.
    J Addict Med; 2021 Sep 01; 15(5):396-405. PubMed ID: 33298749
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Naloxone prescriptions among patients with a substance use disorder and a positive fentanyl urine drug screen presenting to the emergency department.
    Ali SA, Shell J, Harris R, Bedder M.
    Harm Reduct J; 2023 Oct 05; 20(1):144. PubMed ID: 37798673
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont.
    Erath TG, LaCroix R, O'Keefe E, Higgins ST, Rawson RA.
    Harm Reduct J; 2024 Apr 05; 21(1):76. PubMed ID: 38580997
    [Abstract] [Full Text] [Related]

  • 14. Epidemiological trends in opioid-only and opioid/polysubstance-related death rates among American Indian/Alaska Native populations from 1999 to 2019: a retrospective longitudinal ecological study.
    Qeadan F, Madden EF, Mensah NA, Tingey B, Herron J, Hernandez-Vallant A, Venner KL, English K, Dixit A.
    BMJ Open; 2022 May 02; 12(5):e053686. PubMed ID: 35501103
    [Abstract] [Full Text] [Related]

  • 15. URINE TOXICOLOGY PROFILES OF EMERGENCY DEPARTMENT PATIENTS WITH UNTREATED OPIOID USE DISORDER: A MULTI-SITE VIEW.
    Cowan E, Perrone J, Dziura J, Edelman EJ, Hawk K, Herring A, McCormack R, Murphy A, Phadke M, Fiellin DA, D'Onofrio G.
    J Emerg Med; 2023 Oct 02; 65(4):e357-e365. PubMed ID: 37716904
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Attenuation of the Positive-Reinforcing Effects of Ultra-Potent Fentanyl Analogs, Along with Those of Fentanyl and Heroin, During Daily Treatment with Methocinnamox in Rhesus Monkeys.
    Gerak LR, France CP.
    J Pharmacol Exp Ther; 2023 Mar 02; 384(3):363-371. PubMed ID: 36575032
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder.
    Gryczynski J, Nichols H, Schwartz RP, Mitchell SG, Hill P, Wireman K.
    Drug Alcohol Depend; 2019 Nov 01; 204():107515. PubMed ID: 31525569
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.